Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1987 1
1990 1
1992 1
1994 1
1998 1
1999 1
2000 1
2003 1
2004 2
2005 1
2006 2
2007 4
2008 2
2009 7
2010 7
2011 8
2012 8
2013 11
2014 10
2015 17
2016 18
2017 11
2018 16
2019 19
2020 24
2021 21
2022 24
2023 6
Text availability
Article attribute
Article type
Publication date

Search Results

196 results
Results by year
Filters applied: . Clear all
Page 1
Anifrolumab efficacy and safety by type I interferon gene signature and clinical subgroups in patients with SLE: post hoc analysis of pooled data from two phase III trials.
Vital EM, Merrill JT, Morand EF, Furie RA, Bruce IN, Tanaka Y, Manzi S, Kalunian KC, Kalyani RN, Streicher K, Abreu G, Tummala R. Vital EM, et al. Among authors: abreu g. Ann Rheum Dis. 2022 Jul;81(7):951-961. doi: 10.1136/annrheumdis-2021-221425. Epub 2022 Mar 25. Ann Rheum Dis. 2022. PMID: 35338035 Free PMC article. Clinical Trial.
Overview of meta-analysis on prevention and treatment of childhood obesity.
Bahia L, Schaan CW, Sparrenberger K, Abreu GA, Barufaldi LA, Coutinho W, Schaan BD. Bahia L, et al. Among authors: abreu ga. J Pediatr (Rio J). 2019 Jul-Aug;95(4):385-400. doi: 10.1016/j.jped.2018.07.009. Epub 2018 Aug 16. J Pediatr (Rio J). 2019. PMID: 30121174 Free article.
A Randomized, Placebo-Controlled Phase III Extension Trial of the Long-Term Safety and Tolerability of Anifrolumab in Active Systemic Lupus Erythematosus.
Kalunian KC, Furie R, Morand EF, Bruce IN, Manzi S, Tanaka Y, Winthrop K, Hupka I, Zhang LJ, Werther S, Abreu G, Hultquist M, Tummala R, Lindholm C, Al-Mossawi H. Kalunian KC, et al. Among authors: abreu g. Arthritis Rheumatol. 2023 Feb;75(2):253-265. doi: 10.1002/art.42392. Epub 2022 Nov 11. Arthritis Rheumatol. 2023. PMID: 36369793 Clinical Trial.
Immunoglobulin A nephropathy in paediatrics: An up-to-date.
Paranhos RM, De Souza Figueiredo GA, De Abreu GR, Ferreira GC, Fonseca GG, Simões E Silva AC. Paranhos RM, et al. Among authors: de abreu gr. Nephrology (Carlton). 2022 Apr;27(4):307-317. doi: 10.1111/nep.13987. Epub 2021 Oct 29. Nephrology (Carlton). 2022. PMID: 34676611 Review.
Another way to the heart.
Oliveira C, Braga C, Abreu G. Oliveira C, et al. Among authors: abreu g. Acta Cardiol. 2021 Dec;76(10):1139-1140. doi: 10.1080/00015385.2020.1802557. Epub 2020 Aug 12. Acta Cardiol. 2021. PMID: 32783595 No abstract available.
Nanohydroxyapatite/Titanate Nanotube Composites for Bone Tissue Regeneration.
Gusmão SBS, Ghosh A, de Menezes AS, Pereira AFM, Lopes MTP, Souza MK, Dittz D, Abreu GJP, Pinto LSS, Maia Filho ALM, Gusmão GOM, Webster TJ, Lobo AO, Viana BC. Gusmão SBS, et al. Among authors: abreu gjp. J Funct Biomater. 2022 Dec 17;13(4):306. doi: 10.3390/jfb13040306. J Funct Biomater. 2022. PMID: 36547566 Free PMC article.
Triple-Valve Infective Endocarditis: A Case with Unusual Features.
Oliveira I, Vasconcelos G, Bragança B, Cruz M, Abreu G, Azevedo J, Andrade A. Oliveira I, et al. Among authors: abreu g. Eur J Case Rep Intern Med. 2022 Apr 27;9(4):003350. doi: 10.12890/2022_003350. eCollection 2022. Eur J Case Rep Intern Med. 2022. PMID: 35520359 Free PMC article.
196 results